Videos

Get a sneak peek at what’s inside our Winter 2020 issue of Heal Magazine.

Here are the top five CURE® stories for February 2020.

Patients with a compromised immune system are more susceptible to the coronavirus, including those with cancer. Here are four key things patients with cancer should know about the novel coronavirus.

Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.

Here’s a look at what’s inside our 2020 Winter issue.

Treatments for renal cell carcinoma are showing effectiveness in the short term, but with the help of new trials, researchers are looking to expand their impact for long term treatment.

The landscape for patients with renal cell carcinoma could potentially change as the use of immune checkpoint inhibition shows promise for these patients.

A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.